Eliza Broadbent None;
Sandrine H. Künzel None;
Philipp Möller None;
Moritz Linder None;
Lukas Goerdt None;
Joanna Czauderna None;
Steffen Schmitz-Valckenberg AlphaRET, Apellis, Bioeq, Galimedix, Katairo, Kubota Vision, Novartis, PerceiveBiotherapeutics, Pixium, Roche, SparingVision, Code C (Consultant/Contractor), Bayer, Carl Zeiss MediTec, Heidelberg Engineering, Novartis, Roche, Code F (Financial Support), Apellis, Heidelberg Engineering, Code R (Recipient);
Frank Holz Acucela, Alexion, Alzheon, Apellis, Astellas, Bayer, Boehringer Ingelheim, Formycon, Roche/Genentech, Geuder, Grayburg, Gyroscope, HeidelbergEngineering, IvericBio, Janssen, Kanghong, LinBioscience, Novartis, Oxurion, Pixium, StealthBioTherapeutics, Zeiss, Code C (Consultant/Contractor), Acucela, Allergan, Apellis, Bayer, Formycon, CenterVue,Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, Kanghong, Novartis, Optos, Pixium Vision, Zeiss, Code F (Financial Support), GRADE Reading Center, Code O (Owner);
Maximilian Pfau Apellis Pharmaceuticals, Janssen Pharmaceutica, Daiichi Sankyo, Code C (Consultant/Contractor), CenterVue , Code F (Financial Support);
Monika Fleckenstein None